Therapeutic CAS alert advising on use of IL-6 Inhibitors issued by MHRA

Therapeutic CAS alert advising on use of IL-6 Inhibitors issued by MHRA

March 1, 2021

For your information: Tocilizumab letter.

Please see the following letter which has been sent from NHS England  & NHS Improvement – Midlands to CCG ICCs for cascade to Primary Care Clinicians/prescribers including GPs and community pharmacists.

The letter originated from Richard Seal, Regional Chief Pharmacist – Midlands, NHSE&I and approved by the Silver Clinical Oversight Group.

 



Posted in:


More Latest News >

Health and Wellbeing Support Offer

Presentation detailing the health and wellbeing services available to Community Pharmacists and how to access: LLR Primary Care Staff Health...